“Outcomes of Gemcitabine, Vinorelbine, and Doxorubicin in Peripheral T-Cell Lymphoma”. 2024. Archives of Clinical and Medical Case Reports 8 (3): 92-96. https://fortunejournals.org/ojs/index.php/acmcr/article/view/22941.